Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Obviously not
https://find-and-update.company-information.service.gov.uk/company/11330264
pathetic
mol
Would this be good, bad or neutral for PBX?
Amazing what venture capitalists can do with a company
A 1 billion dollar plus sale looks to be on the cards for Probiotix Health biggest customer.
https://ca.news.yahoo.com/probiotics-maker-seed-health-explores-164523574.html
Yes, Bk thanks for posting. Let's hope it gets some mainstream media coverage. (With hopefully some ref to LPldl /PBX).
Esp as yesterday, this was in the news.
https://www.theguardian.com/society/article/2024/jun/05/bowel-disease-hope-researchers-find-biological-pathway
I agree. A pbx rns on this would have provided a boost to the flagging share price. I hope they atleast mention it in the results whenever they are announced.
Thanks for posting that BK and noting the clinically meaningful results ""A multi-species synbiotic (DS-01) alleviates irritable bowel syndrome symptoms while boosting synbiotic consortium: A randomized, double-blind, placebo-controlled clinical trial."
This clinical trial assessed the impact of DS-01® in patients with Irritable Bowel Syndrome (IBS). Key findings include:
DS-01® led to a significant and clinically meaningful improvement in abdominal pain among participants with IBS.
DS-01® led to an enrichment of synbiotic and endogenous beneficial bacteria.
DS-01® led to a significant increase in serotonin in IBS-M participants, a potential mechanism of action.
These presentations will detail the methodology and results from the two clinical trials which have important implications for the application of microbiome science in consumer health and well-being.
Seed's Health clinical data on DS-01® Daily Synbiotic for antibiotic recovery and IBS will be presented in the session "Prebiotics, Probiotics and Synbiotics in Health and Disease" on May 20, 2024, from 12:30 PM to 1:30 PM EDT."
I hat PBX at the very least did not see fit to at least issue a RNS Reach announcing this, after all Seed Health account for most of the re venue generated here so anything that can lead to a meaningful increase in DS01 sales will have a material impact on revenue surely?
With only 1 week to go until Probiota Americas 2024, the leading microbiome industry event, our team is getting ready to head out to Salt Lake City, Utah, and connect with leading experts from around the world.
This year, as a proud gold sponsor at the event, the ProBiotix team will be present with a stand for you to discuss more on how we are leading the way in probiotic research and product solutions for cardiometabolic health. Samples of the new innovative InstaMelt stick formulation will also be available to try and take away.
We'll also be presenting our innovative application concepts for LPLDL®, our award-winning probiotic strain for cardiometabolic health. Don't forget to drop by and say hello to the team.
and there we are
https://probiotaamericas.com/live/en/page/partners
mol
A bit more
https://probiotixhealth.com/free-product-trial-vitafoods/
mol
In fact all product info flyers updated May 2024 - see product info
https://probiotixhealth.com/products/
mol
mol
Flyer uploaded May 2024
https://probiotixhealth.com/wp-content/uploads/2024/05/YourBiotix-InstaMelt-For-Cholesterol-Health-1.pdf
mol
My message (sent for attn of S Andersen) rather than addressed to Walbrook
"Dear Mr Andersen,
I know I am not alone among shareholders in thinking that communication with us, since PBX went alone, has been lacking.
I understood from Walbrook that you were going to set out plans for 2024. We are almost half way through the year, and still nothing.
In the half year figures, orders received though not all booked, had exceeded revenues for all of 2022. Please could you provide a trading update.
Finally, I would love to add to my shareholding, but am loath to do so whilst on Aquis. Please get a listing on PBX. [edit my error, but I think they know I mean AIM]
Many thanks
Martin U"
And Walbrook's response
"Thank you for your email. We had planned to do an update before now, but various external factors prevented this unfortunately. Your comments are noted and I will pass them on to Steen. We will certainly be doing an update at the results."
Such a simple thing to do and file before overdue
https://find-and-update.company-information.service.gov.uk/company/11330264
anybody at home?
mol
mol
1.5m in orders in the first 6 months. We have no way to know if they were all delivered and invoiced in 2023.
They have to announce results by the end of June so not long to wait now.
Yes, i missed this. Thanks.
This is a longer extract from H1 2023.
"During the first half of the financial year the Group received confirmed orders totalling £1.5m which is 16% greater than turnover for the period to 31 December 2022 of £1.31m. Of the orders received, £552k (2021: £302k) had been completed and invoiced as at 30 June 2023. The increase in sales for the first half of the year reflects strong development in new customer acquisition as well as growth from existing customers. Gross profit for the period amounted to £264k (2022: £154k)."
A lot depends on how much of orders are actually booked. And indeed, paid for in reasonable time.
C 5hours ago from the under noted
ProBiotix Health
407 followers
5h
Did you spot us in the latest edition of Nutramedic & Cosmetics in its Vitafoods Europe 2024 preview? Our innovative InstaMelt formulation is launching at the exhibition.
Visit us at stand P56 to learn more, or discover why it's great for cardiometabolic health
yes i did - lol
it's where i got the blurb as posted
https://nmc-magazine.com/vitafoods-europe-2024-preview/
mol
C 3 weeks ago
Steen Dannemann Andersen
Chief Executive Officer & Board member
3w
Dear network
Is there ANY chance that you might know someone, dynamic, driven by “hunting” and all aspects of hands-on sales and customer interaction? Someone who has 3-5 years under the belt and is ready for his or her next professional sales challenge. If you do, please, please put me in contact with that person.
I have a sales job proposal which is hard to resist, in an exceptional organization full of ambitions, entrepreneurship, team spirit and room for shaping own workday to create a healthy work/life balance.
We are committed to support healthy living under the motto “it is not about adding years to life but adding life to years”. Our dedication has led to exceptionally fast growth of the company. Our value proposition is to offer consumers clinically documented natural probiotic supplements supporting maintenance of healthy cholesterol and blood pressure levels throughout life. Our dietary supplement products are brought to market by leading regional and global companies under their own brand.
Our mission is real as almost 20 million people die from cardiovascular diseases every year of which 4 million are directly linked to elevated cholesterol levels. If our products by any means could just fractionally support lowering that numbers our mission is accomplished.
We are expanding rapidly out of our headquarters in Denmark, and the ideal profile would be someone willing to work from HQ as basis, but as the role covers sales in all of Europe, he or she also could be based in another Scandinavian or European country.
hmm...
obviously otherwise engaged martinu to provide the update noted in your approach to Walbrook
anyway 30 June 2024 rapidly approaching re 31 Dec 2023 audited financial statements due
mol
Sales up to the end of June 2023 for H1 were 550k. I don't understand where the 750k comes from?
I looking forward to full year figures for 2023, SOH has mentioned back in April 23 that they had done sales of £750k in first 4 months of 2023 and projected sales of £2.5m for year end - being very profitable.
This stock seems to get forgotten about being on this exchange but I think people will hopefully take more notice after results.
Instamelt? Awkward: https://www.conservingbeauty.com/collections/for-cleansing/products/instamelt%E2%84%A2-day-dissolver-wipes-30-pack
And
https://probiotixhealth.com/probiotix-health-launches-new-innovative-instamelt-formulation-to-support-cardiometabolic-health-at-vitafoods-europe/
https://probiotixhealth.com/healthy-ageing-longevity-and-metabolic-health-a-key-focus-at-vitafoods-europe-2024/
mol
And rebranded to yourbiotix (albeit the old cholbiome still has a presence on clicking a number of the links and of course still on opti online as same)
https://probiotixhealth.com/
https://probiotixhealth.com/products/
mol